• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩里综合征中的动力蛋白激活蛋白1(DCTN1)突变

DCTN1 mutations in Perry syndrome.

作者信息

Farrer Matthew J, Hulihan Mary M, Kachergus Jennifer M, Dächsel Justus C, Stoessl A Jon, Grantier Linda L, Calne Susan, Calne Donald B, Lechevalier Bernard, Chapon Francoise, Tsuboi Yoshio, Yamada Tatsuo, Gutmann Ludwig, Elibol Bülent, Bhatia Kailash P, Wider Christian, Vilariño-Güell Carles, Ross Owen A, Brown Laura A, Castanedes-Casey Monica, Dickson Dennis W, Wszolek Zbigniew K

机构信息

Division of Neurogenetics, Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA.

出版信息

Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.

DOI:10.1038/ng.293
PMID:19136952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2813485/
Abstract

Perry syndrome consists of early-onset parkinsonism, depression, severe weight loss and hypoventilation, with brain pathology characterized by TDP-43 immunostaining. We carried out genome-wide linkage analysis and identified five disease-segregating mutations affecting the CAP-Gly domain of dynactin (encoded by DCTN1) in eight families with Perry syndrome; these mutations diminish microtubule binding and lead to intracytoplasmic inclusions. Our findings show that DCTN1 mutations, previously associated with motor neuron disease, can underlie the selective vulnerability of other neuronal populations in distinct neurodegenerative disorders.

摘要

佩里综合征包括早发性帕金森症、抑郁症、严重体重减轻和通气不足,其脑部病理学特征为TDP-43免疫染色。我们进行了全基因组连锁分析,并在8个佩里综合征家族中鉴定出5个影响动力蛋白(由DCTN1编码)的CAP-Gly结构域的疾病分离突变;这些突变减少了微管结合并导致胞质内包涵体形成。我们的研究结果表明,先前与运动神经元疾病相关的DCTN1突变,可能是不同神经退行性疾病中其他神经元群体选择性易损性的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5702/2813485/e4f654c9b72b/nihms169662f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5702/2813485/fa80b670ae7d/nihms169662f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5702/2813485/e4f654c9b72b/nihms169662f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5702/2813485/fa80b670ae7d/nihms169662f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5702/2813485/e4f654c9b72b/nihms169662f2.jpg

相似文献

1
DCTN1 mutations in Perry syndrome.佩里综合征中的动力蛋白激活蛋白1(DCTN1)突变
Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.
2
Elucidating the genetics and pathology of Perry syndrome.阐明派瑞综合征的遗传学和病理学。
J Neurol Sci. 2010 Feb 15;289(1-2):149-54. doi: 10.1016/j.jns.2009.08.044. Epub 2009 Sep 4.
3
Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.佩里综合征:一种独特类型的TDP-43蛋白病。
J Neuropathol Exp Neurol. 2017 Aug 1;76(8):676-682. doi: 10.1093/jnen/nlx049.
4
DCTN1-related neurodegeneration: Perry syndrome and beyond.与动力蛋白激活蛋白1相关的神经退行性变:佩里综合征及其他。
Parkinsonism Relat Disord. 2017 Aug;41:14-24. doi: 10.1016/j.parkreldis.2017.06.004. Epub 2017 Jun 12.
5
Behavioral defects in a DCTN1 transgenic mouse model of Perry syndrome.佩里综合征DCTN1转基因小鼠模型中的行为缺陷
Neurosci Lett. 2018 Feb 14;666:98-103. doi: 10.1016/j.neulet.2017.12.038. Epub 2017 Dec 19.
6
DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy.DCTN1 F52L 突变型佩里综合征伴进行性核上性麻痹样 tau 病。
Parkinsonism Relat Disord. 2018 Jun;51:105-110. doi: 10.1016/j.parkreldis.2018.02.038. Epub 2018 Feb 23.
7
Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome.伴 Perry 综合征的新型不稳定动力蛋白激活蛋白复合体亚基 1 变异(DCTN1 p.Tyr78His)。
Parkinsonism Relat Disord. 2020 Aug;77:110-113. doi: 10.1016/j.parkreldis.2020.06.006. Epub 2020 Jun 25.
8
Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome.佩里综合征患者诱导多能干细胞衍生的酪氨酸羟化酶阳性神经元中动力蛋白激活蛋白的细胞质聚集体。
Parkinsonism Relat Disord. 2016 Sep;30:67-72. doi: 10.1016/j.parkreldis.2016.06.007. Epub 2016 Jun 15.
9
Establishing diagnostic criteria for Perry syndrome.建立佩里综合征的诊断标准。
J Neurol Neurosurg Psychiatry. 2018 May;89(5):482-487. doi: 10.1136/jnnp-2017-316864. Epub 2017 Oct 31.
10
Behavioral profile in a Dctn1 knock-in mouse model of Perry disease.Perry 病 Dctn1 敲入小鼠模型的行为特征。
Neurosci Lett. 2021 Nov 1;764:136234. doi: 10.1016/j.neulet.2021.136234. Epub 2021 Sep 8.

引用本文的文献

1
Engine breakdown of lysosomes and related organelles and the resulting physiology.溶酶体及相关细胞器的功能障碍及其引发的生理学变化。
Front Cell Dev Biol. 2025 Jun 16;13:1575571. doi: 10.3389/fcell.2025.1575571. eCollection 2025.
2
The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).自噬在肌萎缩侧索硬化症(ALS)和额颞叶痴呆(FTD)的发病机制及治疗中的作用。
Autophagy Rep. 2025 Mar 20;4(1):2474796. doi: 10.1080/27694127.2025.2474796. eCollection 2025.
3
Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression.

本文引用的文献

1
Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review.伴有中枢性低通气、抑郁和体重减轻的快速进展性家族性帕金森病(佩里综合征)——文献综述
Parkinsonism Relat Disord. 2008;14(1):1-7. doi: 10.1016/j.parkreldis.2007.07.014. Epub 2007 Sep 17.
2
Structure-function relationship of CAP-Gly domains.CAP-Gly结构域的结构-功能关系
Nat Struct Mol Biol. 2007 Oct;14(10):959-67. doi: 10.1038/nsmb1291. Epub 2007 Sep 9.
3
Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation.
动力蛋白激活蛋白2通过促进细胞周期进程在肝细胞癌中发挥癌基因作用。
Liver Res. 2022 Aug 11;6(3):155-166. doi: 10.1016/j.livres.2022.07.002. eCollection 2022 Sep.
4
Dynein-driven regulation of postsynaptic membrane architecture and synaptic function.动力蛋白驱动的突触后膜结构和突触功能调控。
J Cell Sci. 2025 Mar 1;138(5). doi: 10.1242/jcs.263844. Epub 2025 Mar 12.
5
TDP-43 Cryptic RNAs in Perry Syndrome: Differences across Brain Regions and TDP-43 Proteinopathies.佩里综合征中的TDP-43隐匿性RNA:脑区差异与TDP-43蛋白病
Mov Disord. 2025 Apr;40(4):662-671. doi: 10.1002/mds.30104. Epub 2025 Jan 9.
6
Decoding TDP-43: the molecular chameleon of neurodegenerative diseases.解析TDP-43:神经退行性疾病中的分子变色龙
Acta Neuropathol Commun. 2024 Dec 31;12(1):205. doi: 10.1186/s40478-024-01914-9.
7
Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases.TDP-43 与其他致病蛋白的共聚集及其在神经退行性疾病中的共病理学。
Int J Mol Sci. 2024 Nov 18;25(22):12380. doi: 10.3390/ijms252212380.
8
Understanding Parkinson disease in Spain: Genetic and clinical insights.西班牙帕金森病研究:遗传学与临床见解
Eur J Neurol. 2025 Jan;32(1):e16499. doi: 10.1111/ene.16499. Epub 2024 Nov 5.
9
First family with Perry syndrome from Mexico.来自墨西哥的首个患有佩里综合征的家族。
Biomed Rep. 2024 Jun 19;21(2):120. doi: 10.3892/br.2024.1808. eCollection 2024 Aug.
10
Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.在肌萎缩侧索硬化症/额颞叶痴呆的果蝇模型中,动力蛋白激活蛋白1(DCTN1)缺乏导致的应激颗粒动力学失调会加剧TDP-43病理变化。
Acta Neuropathol Commun. 2024 Feb 4;12(1):20. doi: 10.1186/s40478-024-01729-8.
50例接受丘脑底核深部脑刺激治疗的帕金森病患者的长期预后
Parkinsonism Relat Disord. 2008;14(2):114-9. doi: 10.1016/j.parkreldis.2007.06.012. Epub 2007 Sep 5.
4
Neurodegeneration involving putative respiratory neurons in Perry syndrome.佩里综合征中涉及假定呼吸神经元的神经退行性变。
Acta Neuropathol. 2008 Feb;115(2):263-8. doi: 10.1007/s00401-007-0246-1. Epub 2007 Jun 19.
5
Key interaction modes of dynamic +TIP networks.动态+TIP网络的关键相互作用模式。
Mol Cell. 2006 Sep 1;23(5):663-71. doi: 10.1016/j.molcel.2006.07.013.
6
A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.动力蛋白激活蛋白p150Glued中与运动神经元疾病相关的突变会扰乱动力蛋白激活蛋白的功能并诱导蛋白质聚集。
J Cell Biol. 2006 Feb 27;172(5):733-45. doi: 10.1083/jcb.200511068.
7
A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules.动力蛋白激活蛋白中的微管结合结构域通过沿微管滑动增加动力蛋白的持续运动能力。
Nat Cell Biol. 2006 Mar;8(3):264-70. doi: 10.1038/ncb1370. Epub 2006 Feb 12.
8
Distal spinal and bulbar muscular atrophy caused by dynactin mutation.动力蛋白激活蛋白突变导致的远端脊髓和延髓肌肉萎缩
Ann Neurol. 2005 May;57(5):687-94. doi: 10.1002/ana.20468.
9
Dynactin.动力蛋白激活蛋白
Annu Rev Cell Dev Biol. 2004;20:759-79. doi: 10.1146/annurev.cellbio.20.012103.094623.
10
Mutant dynactin in motor neuron disease.运动神经元病中的突变动力蛋白激活蛋白
Nat Genet. 2003 Apr;33(4):455-6. doi: 10.1038/ng1123. Epub 2003 Mar 10.